December 22, 2025 · Form 4 insider transaction
ROBIN HOWARD W bought 86,667 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.